Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Metabolsim and Physiological Effects of Argininic acid
Homo sapiens
Metabolic Pathway
Argininic acid is an uremic toxin produced in people with hyperargininemia. Hyperargininemia is an inborn problem in the urea cycle caused by a deficiency in liver arginase. Glutamine is consumed through food and taken into the blood through the intestines. It is transported to the liver where it is transported in via an amino acid transport. Glutamine is then transported into the mitochondria by the transporter glutamate antiporter SLC25A12, mitochondrial. In the mitochondria it is catalyzed by Glutaminase liver isoform, mitochondrial into glutamic acid. Glutamic acid is carboxylated into 1-Pyrroline-5-carboxylic acid by the enzyme Delta-1-pyrroline-5-carboxylate synthase. 1-Pyrroline-5-carboxylic acid with glutaric acid synthesize Oxoglutaric acid and ornithine with the enzyme Ornithine aminotransferase, mitochondrial. Ornithine and Carbamoyl phosphate are catalyzed by the enzyme ornithine carbamoyltransferase, mitochondrial to synthesize citrulline. Citrulline is transported out of the mitochondria into the cytosol by a mitochondrial transporter. Arginnosuccinate is synthesized from citrulline and aspartic acid by the enzyme argininosuccinate synthase. That is catalyzed by argininosuccinate lyase to produce arginine and fumaric acid.
In a healthy individual arginine would then continue in the urea cycle to synthesize urea and ornithine, however, due to the deficiency in arginase, arginine is accumulates in the liver, causing hyperargininemia. This accumulation causes arginine to instead be converted into α-keto-δ-guanidinovaleric acid by transamination. α-Keto-δ-guanidinovaleric acid is then hydrogenated to form argininic acid. Due to the accumulation of arginine, argininic acid is present in high concentrations. Argininic acid is a uremic toxin that is toxic to the nervous system, and it causes various neurlogical disorders such as variable degree of mental retardation, epilepsy and progressive spasticity.
References
Metabolsim and Physiological Effects of Argininic acid References
Monne M, Miniero DV, Daddabbo L, Palmieri L, Porcelli V, Palmieri F: Mitochondrial transporters for ornithine and related amino acids: a review. Amino Acids. 2015 Sep;47(9):1763-77. doi: 10.1007/s00726-015-1990-5. Epub 2015 May 23.
Pubmed: 26002808
Balz D, de Souza Wyse AT, Morsch VM, da Silva AC, Vieira VL, Morsch AL, Schetinger MR: In vitro effects of L-arginine and guanidino compounds on NTPDase1 and 5'-nucleotidase activities from rat brain synaptosomes. Int J Dev Neurosci. 2003 Apr;21(2):75-82. doi: 10.1016/s0736-5748(02)00138-7.
Pubmed: 12615083
Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, Argiles A: Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol. 2012 Jul;23(7):1258-70. doi: 10.1681/ASN.2011121175. Epub 2012 May 24.
Pubmed: 22626821
Monne M, Vozza A, Lasorsa FM, Porcelli V, Palmieri F: Mitochondrial Carriers for Aspartate, Glutamate and Other Amino Acids: A Review. Int J Mol Sci. 2019 Sep 10;20(18). pii: ijms20184456. doi: 10.3390/ijms20184456.
Pubmed: 31510000
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings